Biotransformation, a promising technology for anti-cancer drug development

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Biotechnology

Background:

• Cancer poses a significant global health challenge, necessitating urgent development of effective anti-cancer therapies.
• Biotransformation has emerged as a valuable tool in pharmaceutical research, particularly for anti-cancer drug development.
• Existing anti-cancer drug resources are often limited, driving the need for innovative approaches.

Purpose of the Study:

• To review the diverse applications of biotransformation in the research and development of anti-cancer drugs.
• To explore how biotransformation can be utilized to discover novel anti-cancer compounds.
• To assess the role of biotransformation in enhancing existing anti-cancer drugs and expanding drug resources.

Main Methods:

• Literature review summarizing key advancements and applications of biotransformation in oncology.
• Analysis of three distinct groups of anti-cancer compounds to illustrate practical biotransformation strategies.
• Assessment of biotransformation's role in elucidating anti-cancer drug mechanisms.

Main Results:

• Biotransformation offers significant potential for exploiting novel anti-cancer drug candidates.
• The technique can improve the efficacy and properties of existing anti-cancer medications.
• Biotransformation aids in broadening the scope of anti-cancer drug resources and understanding their mechanisms.

Conclusions:

• Biotransformation is a versatile and effective strategy in the ongoing fight against cancer.
• Its application spans drug discovery, optimization, resource expansion, and mechanistic studies.
• Continued research into biotransformation holds promise for future anti-cancer drug development.